Get the Daily Brief
Latest Biotech News
A*STAR and 10x Genomics launch large spatial biology cancer study
Singapore's A*STAR Genome Institute of Singapore (GIS) and 10x Genomics have initiated the TISHUMAP project to analyze over 2,000 clinical samples using high-resolution spatial transcriptomics...
FDA advisory committee votes against GSK’s Blenrep in multiple myeloma
The FDA’s Oncologic Drugs Advisory Committee voted against endorsing GSK’s Blenrep (belantamab mafodotin) for second-line treatment of multiple myeloma, citing concerns over benefit-risk balance....
Breakthrough mitochondrial donation technique yields healthy births
Newcastle University researchers have reported eight healthy babies born in the UK through mitochondrial donation and pronuclear transfer technology, aimed at preventing maternally inherited...
Johnson & Johnson exceeds $15B in quarterly innovative medicines sales
Johnson & Johnson reported a strong second-quarter performance, with pharmaceutical sales surpassing $15 billion for the first time. The medical devices segment also contributed significantly to...
Biotech venture funding declines in first half of 2025
Biotech venture capital funding slowed markedly in the first half of 2025, as reported by HSBC and BioCentury analyses. Total venture funds raised dropped to approximately $12.7 billion from $16.9...
Medicare Coverage Tightens on Molecular and Transplant Diagnostics
Medicare contractor Palmetto GBA proposed local coverage determinations (LCDs) that impose stricter requirements on molecular diagnostics for ductal carcinoma in situ (DCIS) and transplant...
Sarepta Therapeutics Restructures Amid DMD Therapy Challenges
Sarepta Therapeutics announced a significant workforce reduction, cutting approximately 36% of staff, alongside a strategic pivot from gene therapies to siRNA platforms focused on rare genetic...
UK and Singapore Lead Groundbreaking Mitochondrial IVF Trials
Researchers in the UK reported the successful births of eight healthy children following mitochondrial donation procedures, which involve transferring nuclear DNA from eggs of women with...
Biotech Venture Funding Slows and Market Dynamics Shift
Biotech venture capital funding and initial financing rounds notably declined in the first half of 2025, as highlighted by HSBC and industry analyses, erasing the early-year momentum....
FDA Advisory Committee Voices Concern Over GSK's Blenrep for Multiple Myeloma
The FDA's Oncologic Drugs Advisory Committee voted against GlaxoSmithKline's Blenrep for multiple myeloma, citing unfavorable benefit-risk considerations. High rates of ocular toxicities including...
Johnson & Johnson Reports Strong Q2 Led by Med-Tech and Innovative Medicines
Johnson & Johnson beat expectations in its second-quarter earnings, driven by an $8.54 billion medical device segment showing robust growth, especially in cardiology with over 22% rise. Innovative...
FDA Funds and Regulatory Shifts Impact Biotech Innovation Landscape
Recent actions from the FDA and NIH, including significant staff departures at FDA’s drug center and multiple funding cuts from NIH, have introduced uncertainties in the biotech research and...
Advances in Spatial and Single-Cell Biology Drive Cancer Research
Collaborative initiatives like A*STAR’s TISHUMAP project and companies such as Stratica Biosciences and 10x Genomics are pioneering spatial transcriptomics and AI integration to analyze thousands...
Mitochondrial Donation and IVF Success in Preventing Genetic Diseases
A series of recent studies document successful births of children generated through three-person IVF techniques involving mitochondrial donation. These procedures transplant nuclear DNA from...
Med-Tech and Diagnostics Consolidation with Waters and BD Deal
Waters Corporation and Becton Dickinson (BD) announced a landmark $17.5 billion Reverse Morris Trust transaction, merging BD's Biosciences & Diagnostic Solutions business with Waters. The combined...
10x Genomics and A*STAR launch AI-driven spatial biology for drug discovery
10x Genomics and the A*STAR Genome Institute of Singapore have initiated the TISHUMAP project, leveraging 10x Genomics’ Xenium platform combined with advanced AI to analyze thousands of tissue...
Sarepta Therapeutics restructures amid Duchenne gene therapy safety concerns
Sarepta Therapeutics is executing a major strategic restructuring in response to safety issues linked to its Duchenne muscular dystrophy gene therapy Elevidys, following two patient deaths from...
Johnson & Johnson reports strong Q2 with med-tech growth offsetting Stelara decline
Johnson & Johnson exceeded analysts’ expectations in Q2 2025, driven by medical device sales reaching $8.54 billion and a remarkable 22.3% growth in cardiology. Innovative medicines revenue grew...
Bristol Myers and Pfizer roll out discounted direct-to-consumer Eliquis program
In a move to lower out-of-pocket costs for uninsured, underinsured, and self-pay patients ahead of Medicare price negotiations, Bristol Myers Squibb and Pfizer launched a direct-to-consumer...
Abbott’s Q2 diagnostics sales dip amid COVID testing decline and China policy impact
Abbott reported a 1% decline in its diagnostics segment sales to $2.17 billion in Q2 2025, impacted by a continued decrease in COVID-19 test volumes and China’s volume-based procurement program....